UMB Bank’s Twist Bioscience TWST Stock Holding History

UMB Bank’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-57	Closed	-$2K	–	1976
2022 Q2	$2K	Hold	57	–	–	﹤0.01%	1777
2022 Q1	$3K	Hold	57	–	–	﹤0.01%	1780
2021 Q4	$4K	Buy	+57	New	+$5.85K	﹤0.01%	1703

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

UMB Bank's TWST Position: Q3 2022 in Review

UMB Bank sold out of Twist Bioscience (TWST) in Q3 2022, closing a stake of 57 shares — an estimated $2K sold.

UMB Bank first reported a position in TWST in Q4 2021 and held it in 3 quarters. The position peaked at $4K in Q4 2021. 221 funds tracked by Wall St. Rank hold TWST as of Q3 2022.

UMB Bank reported no remaining Twist Bioscience position as of Q3 2022 after selling out during the quarter.
UMB Bank sold 57 Twist Bioscience shares in Q3 2022, an estimated $2K.
UMB Bank first reported a position in Twist Bioscience in Q4 2021 and held it in 3 quarters.
UMB Bank's Twist Bioscience position peaked at $4K in Q4 2021.
221 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2022.

Based on UMB Bank's 13F filing for Q3 2022, filed 13 Oct 2022.